Tall Cell Variant Thyroid Gland Papillary Carcinoma
3 clinical trials · Condition
◉ Watch Tall Cell Variant Thyroid Gland Papillary Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer (NCT03914300) | National Cancer Institute (NCI) | 2020-02-10 |
| Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) (NCT02973997) | Academic and Community Cancer Research United | 2018-02-07 |
| Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer (NCT01811212) | National Cancer Institute (NCI) | 2013-05-08 |
Track Tall Cell Variant Thyroid Gland Papillary Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.